AAAAAA
Results: 1-25/26
Authors:
Ascioglu, S
Rex, JH
de Pauw, B
Bennett, JE
Bille, J
Crokaert, F
Denning, DW
Donnelly, JP
Edwards, JE
Erjavec, Z
Fiere, D
Lortholary, O
Maertens, J
Meis, JF
Patterson, TF
Ritter, J
Selleslag, D
Shah, PM
Stevens, DA
Walsh, TJ
Citation: S. Ascioglu et al., Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An internationalconsensus, CLIN INF D, 34(1), 2002, pp. 7-14
Authors:
Arikan, S
Rex, JH
Citation: S. Arikan et Jh. Rex, Lipid-based antifungal agents: Current status, CUR PHARM D, 7(5), 2001, pp. 393-415
Authors:
Savary, CA
Grazziutti, ML
Przepiorka, D
Tomasovic, SP
McIntyre, BV
Woodside, DG
Pellis, NR
Pierson, DL
Rex, JH
Citation: Ca. Savary et al., Characteristics of human dendritic cells generated in a microgravity analog culture system, IN VITRO-AN, 37(4), 2001, pp. 216-222
Authors:
Uzon, O
Ascioglu, S
Anaissie, EJ
Rex, JH
Citation: O. Uzon et al., Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. (vol 32, pg 1713, 2001), CLIN INF D, 33(5), 2001, pp. 749-749
Authors:
Sobel, JD
Rex, JH
Citation: Jd. Sobel et Jh. Rex, Invasive candidiasis: Turning risk into a practical prevention policy?, CLIN INF D, 33(2), 2001, pp. 187-190
Authors:
Anaissie, EJ
Kuchar, RT
Rex, JH
Francesconi, A
Kasai, M
Muller, FMC
Lozano-Chiu, M
Summerbell, RC
Dignani, MC
Chanock, SJ
Walsh, TJ
Citation: Ej. Anaissie et al., Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: A new paradigm for the epidemiology of opportunistic mold infections, CLIN INF D, 33(11), 2001, pp. 1871-1878
Authors:
Rex, JH
Walsh, TJ
Nettleman, M
Anaissie, EJ
Bennett, JE
Bow, EJ
Carillo-Munoz, AJ
Chavanet, P
Cloud, GA
Denning, DW
de Pauw, BE
Edwards, JE
Hiemenz, JW
Kauffman, CA
Lopez-Berestein, G
Martino, P
Sobel, JD
Stevens, DA
Sylvester, R
Tollemar, J
Viscoli, C
Viviani, MA
Wu, T
Citation: Jh. Rex et al., Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses, CLIN INF D, 33(1), 2001, pp. 95-106
Authors:
Rex, JH
Sobel, JD
Citation: Jh. Rex et Jd. Sobel, Prophylactic antifungal therapy in the intensive care unit, CLIN INF D, 32(8), 2001, pp. 1191-1200
Authors:
Rex, JH
Walsh, TJ
Sobel, JD
Filler, SG
Pappas, PG
Dismukes, WE
Edwards, JE
Citation: Jh. Rex et al., Reply to Dr. Chandrasekar (Clin Infect Dis 2001; 32 : 320-1) and Drs. Marrand Boeckh (Clin Infect Dis 2001; 32 : 321), CLIN INF D, 32(3), 2001, pp. 518-519
Authors:
Uzun, O
Ascioglu, S
Anaissie, EJ
Rex, JH
Citation: O. Uzun et al., Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia, CLIN INF D, 32(12), 2001, pp. 1713-1717
Authors:
Rex, JH
Pfaller, MA
Walsh, TJ
Chaturvedi, V
Espinel-Ingroff, A
Ghannoum, MA
Gosey, LL
Odds, FC
Rinaldi, MG
Sheehan, DJ
Warnock, DW
Citation: Jh. Rex et al., Antifungal susceptibility testing: Practical aspects and current challenges, CLIN MICROB, 14(4), 2001, pp. 643-658
Authors:
Grazziutti, M
Przepiorka, D
Rex, JH
Braunschweig, I
Vadhan-Raj, S
Savary, CA
Citation: M. Grazziutti et al., Dendritic cell-mediated stimulation of the in vitro lymphocyte response toAspergillus, BONE MAR TR, 27(6), 2001, pp. 647-652
Authors:
Ostrosky-Zeichner, L
Bazemore, S
Paetznick, VL
Rodriguez, JR
Chen, E
Wallace, T
Cossum, P
Rex, JH
Citation: L. Ostrosky-zeichner et al., Differential antifungal activity of isomeric forms of nystatin, ANTIM AG CH, 45(10), 2001, pp. 2781-2786
Authors:
Arikan, S
Lozano-Chiu, M
Paetznick, V
Rex, JH
Citation: S. Arikan et al., In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates, ANTIM AG CH, 45(1), 2001, pp. 327-330
Authors:
Kurtz, MB
Rex, JH
Citation: Mb. Kurtz et Jh. Rex, Glucan synthase inhibitors as antifungal agents, ADV PROTEIN, 56, 2001, pp. 423
Authors:
Tiraboschi, IN
Bennett, JE
Kauffman, CA
Rex, JH
Girmenia, C
Sobel, JD
Menichetti, F
Citation: In. Tiraboschi et al., Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium, MED MYCOL, 38, 2000, pp. 199-204
Authors:
Dupont, B
Brown, HHC
Westermann, K
Martins, MD
Rex, JH
Lortholary, O
Kauffmann, CA
Citation: B. Dupont et al., Mycoses in AIDS, MED MYCOL, 38, 2000, pp. 259-267
Authors:
Rex, JH
Walsh, TJ
Sobel, JD
Filler, SG
Pappas, PG
Dismukes, WE
Edwards, JE
Citation: Jh. Rex et al., Practice guidelines for the treatment of candidiasis, CLIN INF D, 30(4), 2000, pp. 662-678
Authors:
Barry, AL
Pfaller, MA
Brown, SD
Espinel-Ingroff, A
Ghannoum, MA
Knapp, C
Rennie, RP
Rex, JH
Rinaldi, MG
Citation: Al. Barry et al., Quality control limits for broth microdilution susceptibility tests of tenantifungal agents, J CLIN MICR, 38(9), 2000, pp. 3457-3459
Authors:
Rex, JH
Walsh, TJ
Citation: Jh. Rex et Tj. Walsh, Editorial response: Estimating the true cost of amphotericin B, CLIN INF D, 29(6), 1999, pp. 1408-1410
Authors:
Lozano-Chiu, M
Arikan, S
Paetznick, VL
Anaissie, EJ
Rex, JH
Citation: M. Lozano-chiu et al., Optimizing voriconazole susceptibility testing of Candida: Effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility, J CLIN MICR, 37(9), 1999, pp. 2755-2759
Authors:
Lozano-Chiu, M
Nelson, PW
Paetznick, VL
Rex, JH
Citation: M. Lozano-chiu et al., Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991, J CLIN MICR, 37(5), 1999, pp. 1625-1627
Authors:
Arikan, S
Lozano-Chiu, M
Paetznick, V
Nangia, S
Rex, JH
Citation: S. Arikan et al., Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species, J CLIN MICR, 37(12), 1999, pp. 3946-3951
Authors:
Rex, JH
Sobel, JD
Citation: Jh. Rex et Jd. Sobel, Preventing intra-abdominal candidiasis in surgical patients, CRIT CARE M, 27(6), 1999, pp. 1033-1034
Authors:
Marr, KA
Rustad, TR
Rex, JH
White, TC
Citation: Ka. Marr et al., The trailing end point phenotype in antifungal susceptibility testing is pH dependent, ANTIM AG CH, 43(6), 1999, pp. 1383-1386